These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8218783)

  • 21. Compiled report on clinical efficacy and safety of nifedipine retard 10/20/nifedipine CD 30, as a first-line/add-on therapy in patients of hypertension: ENHANS trial.
    Pise M; Korukonda KP; Walwaikar PP
    J Indian Med Assoc; 2009 Feb; 107(2):114-6. PubMed ID: 19585825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of chlorthalidone to slow-release nifedipine in the treatment of arterial hypertension: a controlled study versus placebo.
    Ferrara LA; Marotta T; Pasanisi F; Mastranzo P; Mancini M
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):657-60. PubMed ID: 3154330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nifedipine substituted for minoxidil in the treatment of refractory hypertension.
    Heagerty AM; Bing RF; Thurston H; Swales JD
    J Hum Hypertens; 1987 Sep; 1(2):83-6. PubMed ID: 2906371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does a diuretic cause a further fall in blood pressure in hypertensive patients already on nifedipine?
    Cappuccio FP; Markandu ND; Tucker F; Sagnella GA; MacGregor GA
    J Clin Hypertens; 1986 Dec; 2(4):346-53. PubMed ID: 3806152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical efficacy of Korinfar-retard in combination with Cordanum, triampur and Capoten in patients with arterial hypertension].
    Kukes VG; Ignat'ev VG; Pavlova LI; Rumiantsev AS; Pavlov SS; Privalov AN; Chil'tsov VV
    Klin Med (Mosk); 1996; 74(2):20-3. PubMed ID: 8772094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term effects of captopril versus nifedipine retard on the lipid profile of mild to moderate normolipidemic essential hypertension patients. In representation of the Eastern Andalouz Cooperative Study].
    Aranda P; López S; Aranda FJ; Carmona JR; Frutos MA; López de Novales E
    Rev Clin Esp; 1993 Jun; 193(1):7-11. PubMed ID: 8337465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pharmacokinetics of different drug forms of nifedipine when used singly and in a course as monotherapy and in combination with Cordanum and triampur preparations in patients with arterial hypertension].
    Kukes VG; Ignat'ev VG; Pavlov SS; Starodubtsev AK
    Eksp Klin Farmakol; 1995; 58(6):22-5. PubMed ID: 8704605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nifedipine and essential arterial hypertension refractory to hypotensive therapy: results of a preliminary double-blind study].
    Del Guercio R; Gentile S
    Clin Ter; 1981 Jan; 96(1):45-54. PubMed ID: 7016410
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical effects of a clonidine-chlorthalidone combination in the treatment of arterial hypertension].
    Antonello A; Campanini M; Glorioso S; Borsatti A; Todesco S
    Minerva Med; 1976 Jul; 67(35):2273-81. PubMed ID: 951049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of the delayed-action form of korinfar in arterial hypertension, stenocardia and hypertrophic cardiomyopathy].
    Barats SS; Smolenskaia OG; Klets FKh; Zubareva TV; Zakroeva AG; Kots IaI; Tenchurina LR
    Ter Arkh; 1996; 68(1):39-42. PubMed ID: 8644029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study.
    Saito I; Fujikawa K; Saruta T;
    Hypertens Res; 2008 Jul; 31(7):1399-405. PubMed ID: 18957811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nifedipine retard on heart rate and autonomic balance in patients with ischemic heart disease.
    Sato H; Arai H; Fukuda E; Tsutsumi Y; Yamamoto M; Aizawa T; Long-Tai FL
    Int J Clin Pharmacol Res; 2001; 21(2):65-71. PubMed ID: 11824649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the the combination labetalol plus chlorthalidone in essential arterial hypertension therapy.
    Rossi AG
    Clin Ther; 1981; 3(6):441-9. PubMed ID: 7260990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
    Kraft K; Schiessl S; Vetter H
    Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.